iSpecimen Inc. (ISPC) - Dilution Analysis

S-3 filing: iSpecimen Inc. is filing a shelf registration statement on Form S-3 to offer various securities, including common stock, preferred stock, debt securities, warrants, rights, and units, for total gross proceeds up to $100,000,000.

S-1/A filing: This S-1/A filing registers for resale 1,559,828 shares of iSpecimen Inc.'s common stock, including shares issuable upon exercise of pre-funded warrants, held by selling stockholders from a previous private placement.

S-1/A filing: This is an S-1/A filing for iSpecimen Inc. registering for resale 1,559,828 shares of common stock, including 267,379 shares held by selling stockholders and 1,292,449 shares issuable upon exercise of pre-funded warrants, all from a previous private placement.

S-1 filing: This S-1 filing is for the offer and resale of up to 1,559,828 shares of iSpecimen, Inc. common stock held by selling stockholders, including shares and warrant shares issuable upon exercise of pre-funded warrants.

10-Q filing | 5.5M shares outstanding

8-K filing: iSpecimen Inc. entered into a Securities Purchase Agreement with accredited investors, issuing 1,559,828 shares of common stock (or pre-funded warrants) at $1.122 per share, raising approximately $1.75 million in gross proceeds. ($1.75M proceeds)

S-1/A filing: iSpecimen, Inc. is offering up to 4,040,404 shares of common stock and pre-funded warrants to purchase common stock, with an assumed public offering price of $0.99 per share.

S-1/A filing: iSpecimen Inc. is offering shares of common stock and pre-funded warrants to purchase common stock, with the offering being underwritten by WestPark Capital, Inc.

S-1/A filing: iSpecimen Inc. is offering shares of its common stock and pre-funded warrants in a combination offering underwritten by WestPark Capital, Inc.

S-1/A filing: iSpecimen Inc. is offering common stock and pre-funded warrants, with the offering being underwritten by WestPark Capital, Inc.

10-Q filing | 2.3M shares outstanding

S-1 filing: This S-1 filing is for an offering of common stock and/or pre-funded warrants with WestPark Capital, Inc. as the underwriter, seeking to raise up to $3,000,000, with the intention of using the proceeds for marketing and advertising services, funding an initial milestone payment for SalesStack technology, and for general corporate purposes.

10-K filing | 2.5M shares outstanding

10-Q filing | 1.0M shares outstanding

8-K filing: iSpecimen Inc. completed a public offering on October 31, 2024, issuing 132,814 shares of common stock and pre-funded warrants to purchase up to 1,533,852 shares at $3.00 per share, for gross proceeds of $4,998,464 before fees. ($5.0M proceeds)

S-1 filing: iSpecimen Inc. files an S-1 to offer up to $5,000,000 of Shares and/or Pre-Funded Warrants with the intention to use the net proceeds for the (i) repayment of outstanding debt, (ii) potential acquisitions of assets or investments in businesses, products and technologies that complement our business, (iii) $2,000,000 to IR Agency LLC for marketing and advertising services to communicate information about the Company to the financial community and (iv) the remaining amount for working capital and general corporate purposes.

8-K filing: Stock split 1-for-20 | Outstanding: 13,097,031 → 654,851

10-Q filing | 13.1M shares outstanding

10-Q filing | 9.1M shares outstanding

10-K filing | 9.0M shares outstanding

8-K filing: iSpecimen Inc. entered into a Repurchase Agreement with Warrant Holders to repurchase warrants exercisable for up to 1,312,500 shares of Common Stock at a price of $0.04 per share. ($0.05M proceeds)

10-Q filing | 9.1M shares outstanding

10-Q filing | 9.0M shares outstanding

10-Q filing | 9.0M shares outstanding

10-K filing | 8.8M shares outstanding

10-Q filing | 8.9M shares outstanding

8-K filing: iSpecimen Inc. reports the departure of Christopher Ianelli and Jill Mullan, and new employment agreements with Tracy Curley and Benjamin Bielak, including stock option grants to Curley and Bielak and accelerated vesting of restricted stock units for Ianelli and Mullan as part of their separation agreements.

10-Q filing | 8.8M shares outstanding

S-3 filing: This S-3 filing registers 2,598,473 shares of common stock for resale by selling stockholders of iSpecimen Inc.

S-3 filing: iSpecimen Inc. may offer and sell from time to time, in one or more series, any one of common stock, preferred stock, secured or unsecured debt securities, warrants, rights, or units comprised of, or other combinations of, the foregoing securities, for total gross proceeds up to $100,000,000.

POS AM filing: This prospectus relates to the offer and resale of up to an aggregate of 3,062,499 shares of common stock of iSpecimen Inc. held by selling stockholders.

10-Q filing | 8.8M shares outstanding

10-K filing | 8.8M shares outstanding

8-K filing: iSpecimen Inc. closed a private placement offering of 1,749,999 shares of common stock and warrants exercisable for 1,312,500 shares, for gross proceeds of approximately $21,000,000. ($21.0M proceeds)

10-Q filing | 7.0M shares outstanding

8-K filing: iSpecimen Inc. entered into a Loan and Security Agreement with Bridge Bank for a term loan facility of up to $5,000,000, and issued a warrant to Bridge Bank to purchase up to 12,500 shares of the Company's common stock at an exercise price of $8.00 per share.

10-Q filing | 6.9M shares outstanding

8-K filing: iSpecimen Inc. consummated its initial public offering of 2,250,000 shares of its common stock at an offering price of $8.00 per Share, generating gross proceeds of $18,000,000 and the underwriters exercised their over-allotment option in full, issuing and selling an additional 337,500 Shares at $8.00, generating gross proceeds of $2,700,000. ($20.7M proceeds)

8-K filing: iSpecimen Inc. consummated its initial public offering of 2,250,000 shares of common stock at $8.00 per share, generating gross proceeds of $18,000,000, and also completed the conversion of convertible notes, bridge notes, and preferred stock into common stock. ($18.0M proceeds)

S-1/A filing: This is an S-1/A filing for a common stock offering underwritten by ThinkEquity, a division of Fordham Financial Management, Inc.

S-1/A filing: This is an S-1/A filing for a common stock offering underwritten by ThinkEquity, a division of Fordham Financial Management, Inc.

S-1/A filing: This is an S-1/A filing for a common stock offering underwritten by ThinkEquity.

S-1/A filing: This is an S-1/A filing for a common stock offering underwritten by ThinkEquity, a division of Fordham Financial Management, Inc.

S-1/A filing: This is an S-1/A filing for a common stock offering underwritten by ThinkEquity, a division of Fordham Financial Management, Inc.